Nanofiber Solutions

What Nanofiber Solutions does

Nanofiber Solutions is a privately held biotechnology company founded in 2009 and headquartered in Dublin, Ohio, that designs and manufactures electrospun polycaprolactone (PCL) nanofiber scaffolds marketed to life sciences researchers, surgeons, and veterinary practitioners. The core platform produces three-dimensional scaffolds with an average fiber diameter of approximately 700nm, porosity exceeding 90%, and thicknesses from 200 to 700µm, intended to mimic the extracellular matrix and provide a more physiologically realistic environment for cell growth than traditional 2D polystyrene culture.

The company's product portfolio spans multiple verticals. In 3D cell culture, it offers nanofiber plates (6, 24, 96, and 384-well formats), chamber slides, dishes, plate inserts, and custom 3D scaffolds with both aligned and random fiber orientations, supporting applications in cancer research, stem cell expansion and differentiation, in vitro disease modeling, and drug testing. The Interactive Microenvironment System (IMEMS) is a six-well co-culture platform that enables chemical communication between distinct cell types without physical contact. In regenerative medicine, the company lists the Phoenix Wound Matrix (produced by partner RenovoDerm) and the Rotium Bioresorbable Wick (produced by partner Atreon Ortho) for wound care and rotator cuff repair, respectively. In veterinary medicine, it sells NanoWhiskers™, an injectable, micronized nanofiber product used in equine joint injections for osteoarthritis.

Nanofiber Solutions generates revenue through one-time sales of its consumable and device products via direct website sales and a global distributor network, supplemented by custom scaffold collaborations. No public pricing is disclosed; quotes are obtained through sales inquiries. The company has been funded primarily through a single disclosed $1.5M private round in December 2013 and approximately $916K in National Science Foundation awards between 2012 and 2015, with no subsequent funding rounds visible in the source data. The leadership team includes CEO Ross Kayuha and founders Jed Johnson (also CTO) and John Lannutti.

Name

Nanofiber Solutions

Legal name

Nanofiber Solutions

Website

https://nanofibersolutions.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Nanofiber Solutions is a Dublin, Ohio-based biotech that manufactures electrospun polycaprolactone nanofiber scaffolds for 3D cell culture, regenerative medicine, and veterinary applications, selling directly and through distributors to academic researchers, surgeons, and veterinary practitioners.

Ownership category

akta.pro rank

Product category

3D Cell Culture and Tissue Engineering Consumables

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)

akta.pro secondary industries

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Tissue Engineering & Biomaterial Scaffolds (HLAMANAC), 3D Bioprinting & Biofabrication (HLAAAGAC)

Keywords

• 3D cell culture scaffolds
• Electrospun nanofiber substrates
• Regenerative medicine materials
• Biomimetic tissue scaffolds
• Polycaprolactone nanofibers

Headquarters

HQ city

Columbus

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. 3D Cell Culture Products: Sale of nanofiber scaffolds in various formats including plates, dishes, chamber slides, and inserts for research applications in 3D cell culture, cancer research, stem cell growth, and disease modeling.
2. Veterinary Products: Sale of veterinary medical products including NanoWhiskers injectable cell scaffolds and other regenerative veterinary treatments.
3. Regenerative Medicine Products: Sale of tissue regeneration products including Phoenix Wound Matrix and Rotium Bioresorbable Wick for surgical applications.
4. Custom 3D Scaffolds: Custom-designed nanofiber scaffolds for specific research collaborations and specialized applications.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Nanofiber Solutions designs and manufactures electrospun polycaprolactone (PCL) 3D nanofiber scaffolds that mimic the body's extracellular matrix for 3D cell culture research, regenerative medicine, and veterinary applications. The product portfolio includes standard-format scaffolds (plates, dishes, chamber slides, inserts), custom scaffolds, the IMEMS co-culture system, NanoWhiskers injectable nanofibers, Phoenix Wound Matrix, and Rotium Bioresorbable Wick. Customers are primarily life sciences researchers, pharmaceutical companies, surgeons, and veterinary practitioners.

Product overview

Nanofiber Solutions is a biotechnology company that designs and manufactures novel three-dimensional (3D) nanofiber scaffolds that mimic the extracellular matrix found within the body. Their product portfolio centers on proprietary electrospun polycaprolactone (PCL) nanofiber technology with an average fiber diameter of ~700nm. The core offering includes multiple 3D cell culture formats (Nanofiber Plates, Chamber Slides, Dishes, Plate Inserts, and Custom Scaffolds) designed for applications including cancer research, stem cell growth and differentiation, and in vitro disease models. Additional products target regenerative medicine and veterinary markets, including NanoWhiskers™ for injectable cell scaffold applications, Phoenix Wound Matrix for advanced wound care, and Rotium for orthopedic repair. The scaffolds offer 3x greater surface area than standard tissue culture polystyrene with porosity exceeding 90% and support faster cell expansion rates while maintaining higher percentages of pluripotent stem cells.

Differentiator

Problem solved

Functional benefit

Brands

• Natural Tissue: Technology platform providing surgeons with unparalleled soft tissue feel for regenerative medicine applications.
• IMEMS

Products and services

• Nanofiber Plates

Quantifiable outcome

• 3x greater expansion rate for stem cells on nanofiber scaffolds compared to traditional tissue culture polystyrene
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered minor.

• RenovoDermminorOthersRenovoDerm is a partner company that produces Phoenix Wound Matrix, a synthetic fully bioabsorbable advanced wound care device listed among Nanofiber Solutions' product offerings.
• Atreon OrthominorOthersAtreon Ortho is a partner company that produces Rotium Bioresorbable Wick for rotator cuff injury repair, listed among Nanofiber Solutions' product offerings.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Organogenesis Holdings: Organogenesis commercializes advanced wound care and regenerative medicine products (e.g., Apligraf, Dermagraft), overlapping directly with Nanofiber Solutions' Phoenix Wound Matrix regenerative medicine line. Comparable as a commercial-stage regenerative medicine company targeting wound care and surgical applications.
• MatTek Corporation: MatTek produces standardized 3D in vitro human tissue models (EpiDerm, full-thickness skin) for research and regulatory testing. Comparable as a specialized 3D cell culture tissue model company serving cosmetics, pharma, and chemical safety testing.

Emerging players

• BICO Group (Cellink): BICO (parent of Cellink) provides bioprinters, bioinks, and 3D cell culture solutions for tissue engineering and regenerative medicine. Comparable as an emerging player in the 3D cell/bioprinting space with overlapping pharma and academic customers.

Broad incumbents

• Lonza Group: Lonza provides primary cells, media, and scalable cell-and-gene therapy manufacturing services, including primary human cells and 3D culture reagents. Comparable as a vertically integrated life-sciences platform addressing similar pharma/academic customers.
• DSM Biomedical (dsm-firmenich): DSM Biomedical is a long-established biomaterials supplier to the medical device industry, producing polycaprolactone and other resorbable polymers used in regenerative medicine. Comparable as a biomaterials supplier and partner whose PCL chemistry underpins Nanofiber Solutions' scaffolds.
• Thermo Fisher Scientific: Thermo Fisher offers a broad portfolio of cell culture plastics, 3D culture systems (e.g., Nunclon Sphera), and regenerative medicine tools through its biosciences and specialty diagnostics segments. Directly comparable as the largest scaled alternative for research and clinical scaffold customers.
• Integra LifeSciences: Integra LifeSciences is a major regenerative technologies and orthopedic surgery company (Integra dermal regeneration template, dural repair, and tendon/rotator cuff products like the ArthroFlex patch), overlapping with Nanofiber Solutions' Rotium rotator cuff wick and surgical regenerative applications.
• Corning Life Sciences: Corning is a major incumbent in cell culture consumables (including 3D spheroid plates such as Corning Elplasia) and dominates the tissue culture polystyrene market that Nanofiber Solutions explicitly benchmarks against. Most comparable as the entrenched alternative for 3D cell culture workflows.

Others

• Atreon Ortho: Atreon Ortho produces Rotium, a bioresorbable wick for rotator cuff repair, listed as a Nanofiber Solutions product offering. Comparable as a direct commercial partner in the orthopedic regenerative medicine space.
• RenovoDerm: RenovoDerm produces Phoenix Wound Matrix, which is listed as a Nanofiber Solutions-distributed product. Comparable as a direct commercial partner whose clinical product shares the Nanofiber Solutions distribution channel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/NanoSol
• Facebookfacebook.com/nanofiber-solutions-219033978136515
• LinkedInlinkedin.com/company/nanofiber-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds5 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanofiber Solutions